Eli Lilly

Mangoceuticals, Inc. Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”),…

Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…

Healthcare stocks are hot right now. Several factors are driving them higher, including innovations in areas like heart…

Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…

Dr. Mehmet Oz was front and center Thursday as President Donald Trump unveiled a new deal with two…

New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…

NEW DELHI: Weight-loss therapy drug Eli Lilly’s Mounjaro has become the top selling brand in the domestic pharma…

When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…

WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…

Consumers will soon be able to pick up single-dose vials of the weight loss drug Zepbound at Walmart…

Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…

As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…

Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management